世界の咳過敏症症候群治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cough Hypersensitivity Syndrome Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4059
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、咳過敏症症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮咳薬、吸入コルチコステロイド、抗コリン作用薬、その他）、用途別市場規模（病院、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・咳過敏症症候群治療の市場動向
・企業の競争状況、市場シェア
・咳過敏症症候群治療の種類別市場規模と予測2016-2027（鎮咳薬、吸入コルチコステロイド、抗コリン作用薬、その他）
・咳過敏症症候群治療の用途別市場規模と予測2016-2027（病院、小売薬局、オンライン薬局、その他）
・咳過敏症症候群治療の北米市場規模2016-2027（アメリカ、カナダ）
・咳過敏症症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・咳過敏症症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・咳過敏症症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・咳過敏症症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、GlaxoSmithKline、Boehringer Ingelheim GmbH、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical Industries、Novartis、Merck、Vertex Pharmaceuticals、Johnson & Johnson Consumer）
・結論

Market Analysis and Insights: Global Cough Hypersensitivity Syndrome Treatment Market
The global Cough Hypersensitivity Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cough Hypersensitivity Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cough Hypersensitivity Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cough Hypersensitivity Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cough Hypersensitivity Syndrome Treatment market.

Global Cough Hypersensitivity Syndrome Treatment Scope and Market Size
Cough Hypersensitivity Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cough Hypersensitivity Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antitussive Agents
Inhaled Corticosteroids
Anti-cholinergics
Other

Segment by Application
Hospital
Retail Pharmacy
Online Pharmacies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GlaxoSmithKline
Boehringer Ingelheim GmbH
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical Industries
Novartis
Merck
Vertex Pharmaceuticals
Johnson & Johnson Consumer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cough Hypersensitivity Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antitussive Agents
1.2.3 Inhaled Corticosteroids
1.2.4 Anti-cholinergics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cough Hypersensitivity Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cough Hypersensitivity Syndrome Treatment Market Perspective (2016-2027)
2.2 Cough Hypersensitivity Syndrome Treatment Growth Trends by Regions
2.2.1 Cough Hypersensitivity Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cough Hypersensitivity Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cough Hypersensitivity Syndrome Treatment Industry Dynamic
2.3.1 Cough Hypersensitivity Syndrome Treatment Market Trends
2.3.2 Cough Hypersensitivity Syndrome Treatment Market Drivers
2.3.3 Cough Hypersensitivity Syndrome Treatment Market Challenges
2.3.4 Cough Hypersensitivity Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cough Hypersensitivity Syndrome Treatment Players by Revenue
3.1.1 Global Top Cough Hypersensitivity Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cough Hypersensitivity Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cough Hypersensitivity Syndrome Treatment Revenue
3.4 Global Cough Hypersensitivity Syndrome Treatment Market Concentration Ratio
3.4.1 Global Cough Hypersensitivity Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cough Hypersensitivity Syndrome Treatment Revenue in 2020
3.5 Cough Hypersensitivity Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Cough Hypersensitivity Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Cough Hypersensitivity Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cough Hypersensitivity Syndrome Treatment Breakdown Data by Type
4.1 Global Cough Hypersensitivity Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Cough Hypersensitivity Syndrome Treatment Breakdown Data by Application
5.1 Global Cough Hypersensitivity Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cough Hypersensitivity Syndrome Treatment Market Size (2016-2027)
6.2 North America Cough Hypersensitivity Syndrome Treatment Market Size by Type
6.2.1 North America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Cough Hypersensitivity Syndrome Treatment Market Size by Application
6.3.1 North America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Cough Hypersensitivity Syndrome Treatment Market Size by Country
6.4.1 North America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cough Hypersensitivity Syndrome Treatment Market Size (2016-2027)
7.2 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type
7.2.1 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application
7.3.1 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Country
7.4.1 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cough Hypersensitivity Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type
9.2.1 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application
9.3.1 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Country
9.4.1 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cough Hypersensitivity Syndrome Treatment Introduction
11.1.4 Pfizer Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Cough Hypersensitivity Syndrome Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Cough Hypersensitivity Syndrome Treatment Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Cough Hypersensitivity Syndrome Treatment Introduction
11.4.4 AstraZeneca Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Cough Hypersensitivity Syndrome Treatment Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Cough Hypersensitivity Syndrome Treatment Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Cough Hypersensitivity Syndrome Treatment Introduction
11.7.4 Novartis Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Cough Hypersensitivity Syndrome Treatment Introduction
11.8.4 Merck Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Company Details
11.9.2 Vertex Pharmaceuticals Business Overview
11.9.3 Vertex Pharmaceuticals Cough Hypersensitivity Syndrome Treatment Introduction
11.9.4 Vertex Pharmaceuticals Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.9.5 Vertex Pharmaceuticals Recent Development
11.10 Johnson & Johnson Consumer
11.10.1 Johnson & Johnson Consumer Company Details
11.10.2 Johnson & Johnson Consumer Business Overview
11.10.3 Johnson & Johnson Consumer Cough Hypersensitivity Syndrome Treatment Introduction
11.10.4 Johnson & Johnson Consumer Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Consumer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cough Hypersensitivity Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antitussive Agents
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Anti-cholinergics
Table 5. Key Players of Other
Table 6. Global Cough Hypersensitivity Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cough Hypersensitivity Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cough Hypersensitivity Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cough Hypersensitivity Syndrome Treatment Market Share by Regions (2016-2021)
Table 10. Global Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cough Hypersensitivity Syndrome Treatment Market Share by Regions (2022-2027)
Table 12. Cough Hypersensitivity Syndrome Treatment Market Trends
Table 13. Cough Hypersensitivity Syndrome Treatment Market Drivers
Table 14. Cough Hypersensitivity Syndrome Treatment Market Challenges
Table 15. Cough Hypersensitivity Syndrome Treatment Market Restraints
Table 16. Global Cough Hypersensitivity Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cough Hypersensitivity Syndrome Treatment Market Share by Players (2016-2021)
Table 18. Global Top Cough Hypersensitivity Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cough Hypersensitivity Syndrome Treatment as of 2020)
Table 19. Ranking of Global Top Cough Hypersensitivity Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cough Hypersensitivity Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cough Hypersensitivity Syndrome Treatment Product Solution and Service
Table 23. Date of Enter into Cough Hypersensitivity Syndrome Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cough Hypersensitivity Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Cough Hypersensitivity Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Cough Hypersensitivity Syndrome Treatment Product
Table 66. Pfizer Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Cough Hypersensitivity Syndrome Treatment Product
Table 71. GlaxoSmithKline Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Boehringer Ingelheim GmbH Company Details
Table 74. Boehringer Ingelheim GmbH Business Overview
Table 75. Boehringer Ingelheim GmbH Cough Hypersensitivity Syndrome Treatment Product
Table 76. Boehringer Ingelheim GmbH Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 77. Boehringer Ingelheim GmbH Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Cough Hypersensitivity Syndrome Treatment Product
Table 81. AstraZeneca Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. F. Hoffmann-La Roche Company Details
Table 84. F. Hoffmann-La Roche Business Overview
Table 85. F. Hoffmann-La Roche Cough Hypersensitivity Syndrome Treatment Product
Table 86. F. Hoffmann-La Roche Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 87. F. Hoffmann-La Roche Recent Development
Table 88. Teva Pharmaceutical Industries Company Details
Table 89. Teva Pharmaceutical Industries Business Overview
Table 90. Teva Pharmaceutical Industries Cough Hypersensitivity Syndrome Treatment Product
Table 91. Teva Pharmaceutical Industries Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 92. Teva Pharmaceutical Industries Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Cough Hypersensitivity Syndrome Treatment Product
Table 96. Novartis Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Vertex Pharmaceuticals Company Details
Table 103. Vertex Pharmaceuticals Business Overview
Table 104. Vertex Pharmaceuticals Cough Hypersensitivity Syndrome Treatment Product
Table 105. Vertex Pharmaceuticals Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 106. Vertex Pharmaceuticals Recent Development
Table 107. Johnson & Johnson Consumer Company Details
Table 108. Johnson & Johnson Consumer Business Overview
Table 109. Johnson & Johnson Consumer Cough Hypersensitivity Syndrome Treatment Product
Table 110. Johnson & Johnson Consumer Revenue in Cough Hypersensitivity Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Consumer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cough Hypersensitivity Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antitussive Agents Features
Figure 3. Inhaled Corticosteroids Features
Figure 4. Anti-cholinergics Features
Figure 5. Other Features
Figure 6. Global Cough Hypersensitivity Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Cough Hypersensitivity Syndrome Treatment Report Years Considered
Figure 12. Global Cough Hypersensitivity Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cough Hypersensitivity Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cough Hypersensitivity Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Cough Hypersensitivity Syndrome Treatment Market Share by Regions (2022-2027)
Figure 16. Global Cough Hypersensitivity Syndrome Treatment Market Share by Players in 2020
Figure 17. Global Top Cough Hypersensitivity Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cough Hypersensitivity Syndrome Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cough Hypersensitivity Syndrome Treatment Revenue in 2020
Figure 19. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Cough Hypersensitivity Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cough Hypersensitivity Syndrome Treatment Market Share by Type (2016-2027)
Figure 23. North America Cough Hypersensitivity Syndrome Treatment Market Share by Application (2016-2027)
Figure 24. North America Cough Hypersensitivity Syndrome Treatment Market Share by Country (2016-2027)
Figure 25. United States Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cough Hypersensitivity Syndrome Treatment Market Share by Type (2016-2027)
Figure 29. Europe Cough Hypersensitivity Syndrome Treatment Market Share by Application (2016-2027)
Figure 30. Europe Cough Hypersensitivity Syndrome Treatment Market Share by Country (2016-2027)
Figure 31. Germany Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cough Hypersensitivity Syndrome Treatment Market Share by Region (2016-2027)
Figure 41. China Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cough Hypersensitivity Syndrome Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Cough Hypersensitivity Syndrome Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Cough Hypersensitivity Syndrome Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cough Hypersensitivity Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 68. Vertex Pharmaceuticals Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 69. Johnson & Johnson Consumer Revenue Growth Rate in Cough Hypersensitivity Syndrome Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の過敏性肺炎治療市場規模・現状・予測（2021年-2027年）

Global Hypersensitivity Pneumonitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5792 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、過敏性肺炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（急性、亜急性、慢性）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4315 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特定薬剤治療、化粧品矯正治療）、用途別市場規模（病院、専門医クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界のQT延長症候群治療市場規模・現状・予測（2021年-2027年）

Global Long QT Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4438 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、QT延長症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のアルポート症候群治療市場規模・現状・予測（2021年-2027年）

Global Alport Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5573 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、アルポート症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシン変換酵素（ACE）阻害剤、アンジオテンシン受容体遮断薬（ARB）、利尿剤、その他）、用途別市場規模（病院、診療所、そ...

世界のダンディーウォーカー症候群治療市場規模・現状・予測（2021年-2027年）

Global Dandy-Walker Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5138 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ダンディーウォーカー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（頭蓋骨における外科移植用シャント、複数治療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、...

世界のアイゼンメンジャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Eisenmenger Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5158 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アイゼンメンジャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗不整脈薬、抗凝血剤、エンドセリン受容体拮抗薬、その他）、用途別市場規模（血液検査、心電図（ECG）、胸部X線、心エコー検査...

世界の過敏性肺炎治療市場規模・現状・予測（2021年-2027年） Hypersensitivity pneumonitis is a complex syndrome caused due to exposure to a variety of organic particles. Market Analysis and Insights: Global Hypersensitivity Pneumonitis Treatment Market The global Hypersensitivity Pneumonitis Treatment market size is projected to reach US$ XX million by 2027, …
世界のレット症候群治療市場規模・現状・予測（2021年-2027年） Rett Syndrome is a non-neurological degenerative disease that seriously affects children's psychomotor development. Market Analysis and Insights: Global Rett Syndrome Treatment Market The global Rett Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in …
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
世界のアイゼンメンジャー症候群治療市場規模・現状・予測（2021年-2027年） The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger syndrome is caused due to a birth defect. The disease is characterized by high blood pressure and abnormal blood flow through the heart. The specific symp…